UBS initiated coverage of Emcor (EME) with a Buy rating and $570 price target The company is “poised to outgrow a choppy non-residential construction backdrop,” the analyst tells investors in a research note. The firm believes Emcor’s visibility to continued strong earnings growth in 2026 and 2027 is not sufficiently priced into the shares. UBS sees at least a 7% organic revenue annually through 2027 for the company’s construction businesses, driven by structural investment themes, most notably data centers, semiconductor fabs, and pharmaceutical plants.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EME:
